Afuco™ Anti-Human APOE ADCC Therapeutic Antibody, ADCC Enhanced
Anti-APOE ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. Anti-ApoE antibody is used for treating Alzheimer's disease. Apolipoprotein E (apoE) is the strongest known genetic risk factor for late onset Alzheimer's disease (AD). It influences amyloid-β (Aβ) clearance and aggregation, which likely contributes in large part to its role in AD pathogenesis.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-049CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | APOE |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at –20 or -70°C upon receipt. Divide antibody into aliquots prior usage and avoid multiple freeze-thaw cycles. |